[Retracted] Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma

Figure 5

The MSRS serves as a prognostic indicator for poor outcome in a combined cohort and subcategories. (a) Comparison of MSRS -scores in alive patients (), patients who died within 3 years (), and patients who died between 3 and 6 years (). (b–e) Kaplan–Meier plot indicating the survival probabilities, in terms of overall survival, of HCC patients stratified by their MSRS scores in the (b) whole population or distinguished according to (c) early (left) or (c) late (right) TNM stages, (d) age under 65 (left) or over (d) 65 (right), and (e) gender.

(a)

(b)

(c)

(d)

(e)